Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dysferlin is a large, type II transmembrane protein primarily expressed in skeletal muscle. It plays a critical role in membrane repair, especially of the sarcolemma, and is involved in vesicle trafficking, calcium homeostasis, and other cellular processes related to muscle function. Mutations in the DYSF gene cause dysferlinopathies, notably limb-girdle muscular dystrophy type 2B (LGMD2B) and Miyoshi myopathy, characterized by defective membrane repair and muscle degeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dysferlin (DYSF).